慢性全閉塞デバイス市場(製品タイプ:マイクロカテーテル、ガイドワイヤー、クロッシングデバイス、リエントリーデバイス、その他) - 世界の産業分析、サイズ、シェア、成長、トレンド、および予測、2023-2031年Chronic Total Occlusion Devices Market (Product Type: Microcatheters, Guidewires, Crossing Devices, Re-entry Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031 慢性完全閉塞装置市場 - レポートの範囲 TMRの調査レポート「世界の慢性全閉塞装置市場」は、2023年から2031年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向... もっと見る
このレポートは受注生産にて作成するため
サマリー慢性完全閉塞装置市場 - レポートの範囲TMRの調査レポート「世界の慢性全閉塞装置市場」は、2023年から2031年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会も調査しています。本レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの期間における世界の慢性全閉塞デバイス市場の収益を提供します。また、2023年から2031年までの世界の慢性全閉塞デバイス市場の複合年間成長率(CAGR %)を掲載しています。 本レポートは、広範な調査を経て作成されました。一次調査では、主要なオピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施し、調査作業の大部分を行いました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、慢性閉塞性肺疾患市場を把握した。 また、インターネット上の情報源や政府機関、ウェブサイト、業界団体の統計データも二次調査の対象としています。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、世界の慢性完全閉塞装置市場のさまざまな属性を調査しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、本レポートは、慢性閉塞性肺疾患の世界市場における競争力学の変化に光を当てています。これらは、既存の市場関係者だけでなく、世界の慢性閉塞性肺疾患市場へ参入を検討している企業にとっても貴重なツールになるはずです。 本レポートでは、世界の慢性閉塞性肺疾患市場の競争環境について掘り下げています。世界の慢性閉塞性肺疾患市場で活動する主要企業が特定され、それぞれの企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の慢性閉塞性肺疾患市場のプレイヤーの属性である。 慢性全閉塞装置の世界市場レポートで回答された主な質問 - 予測期間中に全地域で発生した慢性全閉塞デバイスの売上/収益はどの程度か? - 慢性閉塞性肺疾患の世界市場におけるビジネスチャンスは何か? - 市場の主な推進要因、阻害要因、機会、脅威は何か? - 予測期間中に最も速いCAGRで拡大するのはどの地域市場か? - 2031年に世界で最も高い収益を上げると予測されるセグメントは? - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントはどこか? - 世界市場で事業展開している各社の市場ポジションは? 慢性全閉塞装置市場 - 研究目的と研究アプローチ 慢性全閉塞装置の世界市場に関する包括的なレポートは、まず概要から始まり、次に調査範囲と目的について説明しています。本レポートでは、本調査の目的、市場で活動する主要ベンダーと販売業者、製品の承認に関する規制シナリオについて詳しく解説しています。 読みやすさを考慮し、本レポートは章立てでまとめられ、各セクションはより小さなものに分割されています。本レポートは、グラフと表が適切に配置された包括的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えかけています。また、過去と予測期間終了時の主要セグメントの市場シェアを比較することも可能です。 本レポートでは、世界の慢性完全閉塞装置市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントごとの市場シェアを掲載しています。このような貴重な洞察により、市場関係者は、世界の慢性完全閉塞装置市場への投資について、情報に基づいたビジネス上の意思決定を行うことができます。 目次1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Chronic Total Occlusion Devices Market 4. Market Overview 4.1. Introduction 4.1.1. Definition 4.1.2. Industry Evolution /Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Chronic Total Occlusion Devices Market Analysis and Forecast, 2017–2031 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Disease Prevalence & Incidence Rate globally with key countries 5.2. Technological Advancements 5.3. Regulatory Scenario by Region/globally 5.4. COVID-19 Pandemic Impact on Industry 6. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Product Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Product Type, 2017–2031 6.3.1. Microcatheters 6.3.2. Guidewires 6.3.3. Crossing Devices 6.3.4. Re-entry Devices 6.3.5. Others 6.4. Market Attractiveness Analysis, by Product Type 7. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by End-user 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by End-user, 2017–2031 7.3.1. Hospitals 7.3.2. Ambulatory Surgical Centers 7.3.3. Others 7.4. Market Attractiveness Analysis, by End-user 8. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Region 8.1. Key Findings 8.2. Market Value Forecast, by Region 8.2.1. North America 8.2.2. Europe 8.2.3. Asia Pacific 8.2.4. Latin America 8.2.5. Middle East & Africa 8.3. Market Attractiveness Analysis, by Region 9. North America Chronic Total Occlusion Devices Market Analysis and Forecast 9.1. Introduction 9.1.1. Key Findings 9.2. Market Value Forecast, by Product Type, 2017–2031 9.2.1. Microcatheters 9.2.2. Guidewires 9.2.3. Crossing Devices 9.2.4. Re-entry Devices 9.2.5. Others 9.3. Market Value Forecast, by End-user, 2017–2031 9.3.1. Hospitals 9.3.2. Ambulatory Surgical Centers 9.3.3. Others 9.4. Market Value Forecast, by Country, 2017–2031 9.4.1. U.S. 9.4.2. Canada 9.5. Market Attractiveness Analysis 9.5.1. By Product Type 9.5.2. By End-user 9.5.3. By Country 10. Europe Chronic Total Occlusion Devices Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Product Type, 2017–2031 10.2.1. Microcatheters 10.2.2. Guidewires 10.2.3. Crossing Devices 10.2.4. Re-entry Devices 10.2.5. Others 10.3. Market Value Forecast, by End-user, 2017–2031 10.3.1. Hospitals 10.3.2. Ambulatory Surgical Centers 10.3.3. Others 10.4. Market Value Forecast, by Country/Sub-region, 2017–2031 10.4.1. Germany 10.4.2. U.K. 10.4.3. France 10.4.4. Spain 10.4.5. Italy 10.4.6. Rest of Europe 10.5. Market Attractiveness Analysis 10.5.1. By Product Type 10.5.2. By End-user 10.5.3. By Country/Sub-region 11. Asia Pacific Chronic Total Occlusion Devices Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Product Type, 2017–2031 11.2.1. Microcatheters 11.2.2. Guidewires 11.2.3. Crossing Devices 11.2.4. Re-entry Devices 11.2.5. Others 11.3. Market Value Forecast, by End-user, 2017–2031 11.3.1. Hospitals 11.3.2. Ambulatory Surgical Centers 11.3.3. Others 11.4. Market Value Forecast, by Country/Sub-region, 2017–2031 11.4.1. China 11.4.2. Japan 11.4.3. India 11.4.4. Australia & New Zealand 11.4.5. Rest of Asia Pacific 11.5. Market Attractiveness Analysis 11.5.1. By Product Type 11.5.2. By End-user 11.5.3. By Country/Sub-region 12. Latin America Chronic Total Occlusion Devices Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Product Type, 2017–2031 12.2.1. Microcatheters 12.2.2. Guidewires 12.2.3. Crossing Devices 12.2.4. Re-entry Devices 12.2.5. Others 12.3. Market Value Forecast, by End-user, 2017–2031 12.3.1. Hospitals 12.3.2. Ambulatory Surgical Centers 12.3.3. Others 12.4. Market Value Forecast, by Country/Sub-region, 2017–2031 12.4.1. Brazil 12.4.2. Mexico 12.4.3. Rest of Latin America 12.5. Market Attractiveness Analysis 12.5.1. By Product Type 12.5.2. By End-user 12.5.3. By Country/Sub-region 13. Middle East & Africa Chronic Total Occlusion Devices Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Product Type, 2017–2031 13.2.1. Microcatheters 13.2.2. Guidewires 13.2.3. Crossing Devices 13.2.4. Re-entry Devices 13.2.5. Others 13.3. Market Value Forecast, by End-user, 2017–2031 13.3.1. Hospitals 13.3.2. Ambulatory Surgical Centers 13.3.3. Others 13.4. Market Value Forecast, by Country/Sub-region, 2017–2031 13.4.1. GCC Countries 13.4.2. South Africa 13.4.3. Rest of Middle East & Africa 13.5. Market Attractiveness Analysis 13.5.1. By Product Type 13.5.2. By End-user 13.5.3. By Country/Sub-region 14. Competition Landscape 14.1. Market Player - Competition Matrix (by tier and size of companies) 14.2. Market Share Analysis, by Company, 2022 14.3. Company Profiles 14.3.1. Medtronic 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.1.2. Product Type Portfolio 14.3.1.3. Financial Overview 14.3.1.4. SWOT Analysis 14.3.1.5. Strategic Overview 14.3.2. Boston Scientific Corporation 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2.2. Product Type Portfolio 14.3.2.3. Financial Overview 14.3.2.4. SWOT Analysis 14.3.2.5. Strategic Overview 14.3.3. Acrostak Int. Distr. Sàrl 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.3.2. Product Type Portfolio 14.3.3.3. Financial Overview 14.3.3.4. SWOT Analysis 14.3.3.5. Strategic Overview 14.3.4. Abbott 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.4.2. Product Type Portfolio 14.3.4.3. Financial Overview 14.3.4.4. SWOT Analysis 14.3.4.5. Strategic Overview 14.3.5. Asahi Intecc Co., Ltd. 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.5.2. Product Type Portfolio 14.3.5.3. Financial Overview 14.3.5.4. SWOT Analysis 14.3.5.5. Strategic Overview 14.3.6. Cardinal Health 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.6.2. Product Type Portfolio 14.3.6.3. Financial Overview 14.3.6.4. SWOT Analysis 14.3.6.5. Strategic Overview 14.3.7. Cook Medical 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.7.2. Product Type Portfolio 14.3.7.3. Financial Overview 14.3.7.4. SWOT Analysis 14.3.7.5. Strategic Overview 14.3.8. Merit Medical Systems 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.8.2. Product Type Portfolio 14.3.8.3. Financial Overview 14.3.8.4. SWOT Analysis 14.3.8.5. Strategic Overview 14.3.9. MicroPort Scientific Corporation 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.9.2. Product Type Portfolio 14.3.9.3. Financial Overview 14.3.9.4. SWOT Analysis 14.3.9.5. Strategic Overview 14.3.10. Penumbra, Inc. 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.10.2. Product Type Portfolio 14.3.10.3. Financial Overview 14.3.10.4. SWOT Analysis 14.3.10.5. Strategic Overview 14.3.11. Koninklijke Philips N.V. 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.11.2. Product Type Portfolio 14.3.11.3. Financial Overview 14.3.11.4. SWOT Analysis 14.3.11.5. Strategic Overview 14.3.12. Terumo India Private Limited 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.12.2. Product Type Portfolio 14.3.12.3. Financial Overview 14.3.12.4. SWOT Analysis 14.3.12.5. Strategic Overview 14.3.13. Teleflex Incorporated 14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.13.2. Product Type Portfolio 14.3.13.3. Financial Overview 14.3.13.4. SWOT Analysis 14.3.13.5. Strategic Overview 14.3.14. Becton, Dickinson and Company 14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.14.2. Product Type Portfolio 14.3.14.3. Financial Overview 14.3.14.4. SWOT Analysis 14.3.14.5. Strategic Overview 14.3.15. Reflow Medical 14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.15.2. Product Type Portfolio 14.3.15.3. Financial Overview 14.3.15.4. SWOT Analysis 14.3.15.5. Strategic Overview 14.3.16. Nitiloop 14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.16.2. Product Type Portfolio 14.3.16.3. Financial Overview 14.3.16.4. SWOT Analysis 14.3.16.5. Strategic Overview 図表リストList of TablesTable 01: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031 Table 02: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031 Table 03: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031 Table 04: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031 Table 05: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031 Table 06: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031 Table 07: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031 Table 08: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031 Table 09: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031 Table 10: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031 Table 11: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031 Table 12: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031 Table 13: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031 Table 14: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031 Table 15: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031 Table 16: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031 Table 17: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031 Table 18: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
SummaryChronic Total Occlusion Devices Market – Scope of Report Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Chronic Total Occlusion Devices Market 4. Market Overview 4.1. Introduction 4.1.1. Definition 4.1.2. Industry Evolution /Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Chronic Total Occlusion Devices Market Analysis and Forecast, 2017–2031 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Disease Prevalence & Incidence Rate globally with key countries 5.2. Technological Advancements 5.3. Regulatory Scenario by Region/globally 5.4. COVID-19 Pandemic Impact on Industry 6. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Product Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Product Type, 2017–2031 6.3.1. Microcatheters 6.3.2. Guidewires 6.3.3. Crossing Devices 6.3.4. Re-entry Devices 6.3.5. Others 6.4. Market Attractiveness Analysis, by Product Type 7. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by End-user 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by End-user, 2017–2031 7.3.1. Hospitals 7.3.2. Ambulatory Surgical Centers 7.3.3. Others 7.4. Market Attractiveness Analysis, by End-user 8. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Region 8.1. Key Findings 8.2. Market Value Forecast, by Region 8.2.1. North America 8.2.2. Europe 8.2.3. Asia Pacific 8.2.4. Latin America 8.2.5. Middle East & Africa 8.3. Market Attractiveness Analysis, by Region 9. North America Chronic Total Occlusion Devices Market Analysis and Forecast 9.1. Introduction 9.1.1. Key Findings 9.2. Market Value Forecast, by Product Type, 2017–2031 9.2.1. Microcatheters 9.2.2. Guidewires 9.2.3. Crossing Devices 9.2.4. Re-entry Devices 9.2.5. Others 9.3. Market Value Forecast, by End-user, 2017–2031 9.3.1. Hospitals 9.3.2. Ambulatory Surgical Centers 9.3.3. Others 9.4. Market Value Forecast, by Country, 2017–2031 9.4.1. U.S. 9.4.2. Canada 9.5. Market Attractiveness Analysis 9.5.1. By Product Type 9.5.2. By End-user 9.5.3. By Country 10. Europe Chronic Total Occlusion Devices Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Product Type, 2017–2031 10.2.1. Microcatheters 10.2.2. Guidewires 10.2.3. Crossing Devices 10.2.4. Re-entry Devices 10.2.5. Others 10.3. Market Value Forecast, by End-user, 2017–2031 10.3.1. Hospitals 10.3.2. Ambulatory Surgical Centers 10.3.3. Others 10.4. Market Value Forecast, by Country/Sub-region, 2017–2031 10.4.1. Germany 10.4.2. U.K. 10.4.3. France 10.4.4. Spain 10.4.5. Italy 10.4.6. Rest of Europe 10.5. Market Attractiveness Analysis 10.5.1. By Product Type 10.5.2. By End-user 10.5.3. By Country/Sub-region 11. Asia Pacific Chronic Total Occlusion Devices Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Product Type, 2017–2031 11.2.1. Microcatheters 11.2.2. Guidewires 11.2.3. Crossing Devices 11.2.4. Re-entry Devices 11.2.5. Others 11.3. Market Value Forecast, by End-user, 2017–2031 11.3.1. Hospitals 11.3.2. Ambulatory Surgical Centers 11.3.3. Others 11.4. Market Value Forecast, by Country/Sub-region, 2017–2031 11.4.1. China 11.4.2. Japan 11.4.3. India 11.4.4. Australia & New Zealand 11.4.5. Rest of Asia Pacific 11.5. Market Attractiveness Analysis 11.5.1. By Product Type 11.5.2. By End-user 11.5.3. By Country/Sub-region 12. Latin America Chronic Total Occlusion Devices Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Product Type, 2017–2031 12.2.1. Microcatheters 12.2.2. Guidewires 12.2.3. Crossing Devices 12.2.4. Re-entry Devices 12.2.5. Others 12.3. Market Value Forecast, by End-user, 2017–2031 12.3.1. Hospitals 12.3.2. Ambulatory Surgical Centers 12.3.3. Others 12.4. Market Value Forecast, by Country/Sub-region, 2017–2031 12.4.1. Brazil 12.4.2. Mexico 12.4.3. Rest of Latin America 12.5. Market Attractiveness Analysis 12.5.1. By Product Type 12.5.2. By End-user 12.5.3. By Country/Sub-region 13. Middle East & Africa Chronic Total Occlusion Devices Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Product Type, 2017–2031 13.2.1. Microcatheters 13.2.2. Guidewires 13.2.3. Crossing Devices 13.2.4. Re-entry Devices 13.2.5. Others 13.3. Market Value Forecast, by End-user, 2017–2031 13.3.1. Hospitals 13.3.2. Ambulatory Surgical Centers 13.3.3. Others 13.4. Market Value Forecast, by Country/Sub-region, 2017–2031 13.4.1. GCC Countries 13.4.2. South Africa 13.4.3. Rest of Middle East & Africa 13.5. Market Attractiveness Analysis 13.5.1. By Product Type 13.5.2. By End-user 13.5.3. By Country/Sub-region 14. Competition Landscape 14.1. Market Player - Competition Matrix (by tier and size of companies) 14.2. Market Share Analysis, by Company, 2022 14.3. Company Profiles 14.3.1. Medtronic 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.1.2. Product Type Portfolio 14.3.1.3. Financial Overview 14.3.1.4. SWOT Analysis 14.3.1.5. Strategic Overview 14.3.2. Boston Scientific Corporation 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2.2. Product Type Portfolio 14.3.2.3. Financial Overview 14.3.2.4. SWOT Analysis 14.3.2.5. Strategic Overview 14.3.3. Acrostak Int. Distr. Sàrl 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.3.2. Product Type Portfolio 14.3.3.3. Financial Overview 14.3.3.4. SWOT Analysis 14.3.3.5. Strategic Overview 14.3.4. Abbott 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.4.2. Product Type Portfolio 14.3.4.3. Financial Overview 14.3.4.4. SWOT Analysis 14.3.4.5. Strategic Overview 14.3.5. Asahi Intecc Co., Ltd. 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.5.2. Product Type Portfolio 14.3.5.3. Financial Overview 14.3.5.4. SWOT Analysis 14.3.5.5. Strategic Overview 14.3.6. Cardinal Health 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.6.2. Product Type Portfolio 14.3.6.3. Financial Overview 14.3.6.4. SWOT Analysis 14.3.6.5. Strategic Overview 14.3.7. Cook Medical 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.7.2. Product Type Portfolio 14.3.7.3. Financial Overview 14.3.7.4. SWOT Analysis 14.3.7.5. Strategic Overview 14.3.8. Merit Medical Systems 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.8.2. Product Type Portfolio 14.3.8.3. Financial Overview 14.3.8.4. SWOT Analysis 14.3.8.5. Strategic Overview 14.3.9. MicroPort Scientific Corporation 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.9.2. Product Type Portfolio 14.3.9.3. Financial Overview 14.3.9.4. SWOT Analysis 14.3.9.5. Strategic Overview 14.3.10. Penumbra, Inc. 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.10.2. Product Type Portfolio 14.3.10.3. Financial Overview 14.3.10.4. SWOT Analysis 14.3.10.5. Strategic Overview 14.3.11. Koninklijke Philips N.V. 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.11.2. Product Type Portfolio 14.3.11.3. Financial Overview 14.3.11.4. SWOT Analysis 14.3.11.5. Strategic Overview 14.3.12. Terumo India Private Limited 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.12.2. Product Type Portfolio 14.3.12.3. Financial Overview 14.3.12.4. SWOT Analysis 14.3.12.5. Strategic Overview 14.3.13. Teleflex Incorporated 14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.13.2. Product Type Portfolio 14.3.13.3. Financial Overview 14.3.13.4. SWOT Analysis 14.3.13.5. Strategic Overview 14.3.14. Becton, Dickinson and Company 14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.14.2. Product Type Portfolio 14.3.14.3. Financial Overview 14.3.14.4. SWOT Analysis 14.3.14.5. Strategic Overview 14.3.15. Reflow Medical 14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.15.2. Product Type Portfolio 14.3.15.3. Financial Overview 14.3.15.4. SWOT Analysis 14.3.15.5. Strategic Overview 14.3.16. Nitiloop 14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.16.2. Product Type Portfolio 14.3.16.3. Financial Overview 14.3.16.4. SWOT Analysis 14.3.16.5. Strategic Overview List of Tables/GraphsList of TablesTable 01: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031 Table 02: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031 Table 03: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031 Table 04: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031 Table 05: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031 Table 06: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031 Table 07: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031 Table 08: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031 Table 09: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031 Table 10: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031 Table 11: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031 Table 12: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031 Table 13: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031 Table 14: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031 Table 15: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031 Table 16: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031 Table 17: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031 Table 18: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
Transparency Market Research 社の最新刊レポート
本レポートと同じKEY WORD(industry)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/09 10:27 143.78 円 159.73 円 191.51 円 |